President and CEO of CARE USA to Speak at Heller Commencement

May 02, 2008

Dr. Helene Gayle, President and CEO of CARE USA, one of the world's premier international relief and development organizations, will deliver the commencement address at Heller's commencement ceremony on May 18.

With programs in over 60 countries, CARE helps people in poor communities expand the control they have over their own lives to advance positive, enduring social change. Women are at the heart of CARE's community-based efforts to improve education, prevent the spread of HIV, increase access to water and sanitation, expand economic opportunity and protect natural resources. CARE advocates for polices that defend the dignity of all people and promote the eradication of poverty.

Dr. Gayle's accomplishments in public health and dedication to social service make her ideally suited to lead CARE. She is currently on the boards of the Institute of Medicine and the Council on Foreign Relations. She worked for the Centers for Disease Control and Prevention for 20 years in a variety of positions, from staff epidemiologist to director for the National Center for HIV, STD and TB Prevention. Prior to assuming her current position, she was director of the HIV, TB and Reproductive Health Program at the Bill and Melinda Gates Foundation. Dr. Gayle received her medical degree from the University of Pennsylvania and master's in public health from John Hopkins University, and is a graduate of Barnard College of Columbia University.

Also in the News

Judge Kavanaugh’s Supreme Court Nomination Could Put the Americans With Disabilities Act in Danger

July 26, 2018

In Rewire.News, Robyn Powell says 28-years-ago, the Americans with Disabilities Act (ADA) became law. But Judge Kavanaugh’s Supreme Court Nomination nomination could threaten it.

Inside Google’s Shadow Workforce

July 25, 2018

In Bloomberg, David Weil says we have allowed businesses to really sever their responsibility for more and more of the people who create value.

The Health 202: ACA’s medical device tax once again on the chopping block

July 25, 2018

In the Washington Post, Andrew Kolodny says it was interesting that Purdue Pharma seemed to initially acknowledge the risk of opioid prescriptions.

News Archive →